To test this, we employed HH inhibitor GANT61, and the reagent blocked the rTGFβ1 effects on hBMECs, and rTGFβ1 treatment was incapable of reducing the upregulation of IL-6, MIP-2, and E-selectin upon RS218 infection. The gene discussed is IL6; the disease is infection.